A systematic review and critical assessment of health state utilities: Weight change and type 2 diabetes mellitus

PharmacoEconomics

Volumn 30, Issue 12, 2012, Pages 1133-1143

  Doyle, Scott ^a,b   Lloyd, Andrew ^a   Moore, Lee ^c   Ray, Joshua ^d   Gray, Alastair ^b  

^a ICON PLC   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROCHE PRODUCTS LTD   (United Kingdom)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Pharmacoeconomics; Type 2 diabetes mellitus; Utility measurement; Weight gain; Weight loss

Indexed keywords

BODY MASS; BODY WEIGHT; COST UTILITY ANALYSIS; DIABETIC PATIENT; HEALTH STATUS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; SYSTEMATIC REVIEW; WEIGHT GAIN; WEIGHT REDUCTION;

BODY WEIGHT; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; HEALTH STATUS; HUMANS; MODELS, ECONOMIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84869201188     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11599420-000000000-00000     Document Type: Review

References (39)

1. Williams A. Economics of coronary artery bypass grafting. Br Med J (Clin Res Ed) 1985 Aug 3; 291 (6491): 326-9 (Pubitemid 15045122)
2. Brazier J. Valuing health states for use in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 769-79
3. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008 [online]. Available from URL: Http://www.nice.org. uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [Accessed 2010 Apr 10]
4. Terwee CB, Jansma EP, Riphagen II, et al. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res 2009 Oct; 18 (8): 1115-23
5. Mokkink LB, Terwee CB, Stratford PW, et al. Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res 2009 Apr; 18 (3): 313-33
6. Brazier J, Papaioannou P, Cantrell A, et al. Identifying and reviewing health state utility values for populating decision models. In: Shemilt I, Mugford M, Vale L, et al., editors. Evidence-based decisions and economics: Health care, social welfare, education and criminal justice. 2nd rev. ed. Oxford: BMJ Books, 2010: 93-105
7. Beverley C, Ryan A. Quality of life sample search filter [online]. Available from URL: Http://www.york.ac.uk/inst/ crd/intertasc/qol1.htm [Accessed 2009 Nov 10]
8. Lloyd A, Wild D, Gallop K, et al. Reimbursement agency requirements for health related quality-of-life data: A case study. Expert Rev Pharmacoecon Outcomes Res 2009 Dec; 9 (6): 527-37
9. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005 Mar; 14 (3): 217-30 (Pubitemid 40360759)
10. Brennan A, Ara R, Sterz R, et al. Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. Eur J Health Econ 2006 Dec; 7 (4): 276-84
11. Ara R, Brennan A. The cost-effectiveness of sibutramine in non-diabetic obese patients: evidence from four Western countries. Obes Rev 2007 Jul; 8 (4): 363-71 (Pubitemid 46944497)
12. Kolotkin RL, Norquist JM, Crosby RD, et al. One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Health Qual Life Outcomes 2009 Jun 9; 7: 53
13. Kortt MA, Clarke PM. Estimating utility values for health states of overweight and obese individuals using the SF-36. Qual Life Res 2005 Dec; 14 (10): 2177-85 (Pubitemid 41674420)
14. Lee AJ, Morgan CL, Morrissey M, et al. Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with type 1 diabetes, type 2 diabetes and with no diagnosed diabetes. Diabet Med 2005 Nov; 22 (11): 1482-6 (Pubitemid 41641152)
15. Macran S. The relationship between body mass index and health-related quality of life [discussion paper no. 190]. York: Centre for Health Economics, University of York, 2004
16. Matza LS, Boye KS, Yurgin N, et al. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007 Sep; 16 (7): 1251-65 (Pubitemid 47357727)
17. Sach TH, Barton GR, Doherty M, et al. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. Int J Obes (Lond) 2007 Jan; 31 (1): 189-96 (Pubitemid 46006033)
18. Soltoft F, Hammer M, Kragh N. The association of body mass index and health-related quality of life in the general population: Data from the 2003 Health Survey of England. Qual Life Res 2009; 18: 1293-9
19. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009 Jul; 339: B2535
20. National Institute for Health and Clinical Excellence. Obesity: The prevention, identification, assessment and management of overweight and obesity in adults and children [clinical guideline no. 43]. London: NICE, 2006 [online]. Available from URL: Http://www.nice.org.uk/guidance/ cg43 [Accessed 2010 Apr 12]
21. Ara R, Brennan A. Economic evaluation of sibutramine for the treatment of obesity in adults without other comorbidities in the UK. Sheffield: School of Health and Related Research (ScHARR), University of Sheffield, 2005
22. National Institute for Health and Clinical Excellence. Type 2 diabetes (partially updated by CG87) [clinical guideline no. CG66]. London: NICE, 2008 [online]. Available from URL: Http://guidance.nice.org.uk/CG66 [Accessed 2012 Sep 13]
23. National Institute for Health and Clinical Excellence. Type 2 diabetes: Newer agents (partial update of CG66) [clinical guideline no. CG87]. London: NICE, 2009 [online]. Available from URL: Http://www.nice.org.uk/CG87 [Accessed 2012 Sep 13]
24. Palmer AJ, Roze S, Valentine WJ, et al. The CORE diabetes model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004 Aug; 20 Suppl. 1: S5-26
25. Tsai AG, Wadden TA, Sarwer DB, et al. Metabolic syndrome and health-related quality of life in obese individuals seeking weight reduction. Obesity (Silver Spring) 2008 Jan; 16 (1): 59-63 (Pubitemid 351271950)
26. Barnett TE, Chumbler NR, Vogel WB, et al. The cost-utility of a care coordination/home telehealth programme for veterans with diabetes. J Telemed Telecare 2007; 13 (6): 318-21
27. Brown SE, Meltzer DO, Chin MH, et al. Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients. J Am Geriatr Soc 2008 Jul; 56 (7): 1183-90
28. Currie CJ, McEwan P, Peters JR, et al. The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): Descriptive analysis from the first 20,000 subjects. Value Health 2005 Sept- Oct; 8 (5): 581-90 (Pubitemid 41727307)
29. Gusi N, Garcia J, Gonzalez-Guerrero J, et al. Cost-utility of a walking programme for moderately depressed, obese, or overweight elderly women in primary care: A randomized controlled trial. BMC Public Health 2008; 8: 231
30. Neovius M, Narbro K. Cost-effectiveness of pharmacological anti-obesity treatments: A systematic review. Int J Obes (Lond) 2008; 32 (12): 1752-63
31. Roux L, Donaldson C, Goldie S, et al. Economic evaluation of weight loss interventions in overweight and obese women. Obesity (Silver Spring) 2006 Jun; 14 (6): 1093-106 (Pubitemid 46219711)
32. Rejeski WJ, Lang W, Neiberg RH, et al. Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. Obesity (Silver Spring) 2006 May; 14 (5): 870-83 (Pubitemid 46219729)
33. Dennett SL, Boye KS, Yurgin NR. The impact of body weight on patient utilities with or without type 2 diabetes: A review of the medical literature. Value Health 2008 May-Jun; 11 (3): 478-86 (Pubitemid 351712974)
34. Matza LS, Yurgin N, Boye KS, et al. Obese versus nonobese patients with type 2 diabetes: Patient-reported outcomes and utility of weight change. Curr Med Res Opin 2007 Sep; 23 (9): 2051-62 (Pubitemid 350246593)
35. Groessl EJ, Kaplan RM, Barrett-Connor E, et al. Body mass index and quality of well-being in a community of older adults. Am J Prev Med 2004 Feb; 26 (2): 126-9 (Pubitemid 38134439)
36. Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 health survey. J Clin Epidemiol 1998 Nov; 51 (11): 1115-28 (Pubitemid 28527167)
37. Hakim Z, Wolf A, Garrison LP. Estimating the effect of changes in body mass index on health state preferences. Pharmacoeconomics 2002; 20 (6): 393-404 (Pubitemid 34712971)
38. Torrance GW. Utility measurement in healthcare: The things I never got to. Pharmacoeconomics 2006; 24 (11): 1069-78 (Pubitemid 44683364)
39. Papaioannou D, Brazier J, Paisley S, on behalf of the Decision Support Unit. The identification, review and synthesis of health state utility values from the literature [NICE DSU technical support document no. 9]. Sheffield: School of Health and Related Research (ScHARR), University of Sheffield, 2010 [online]. Available from URL: Http://www.nicedsu.org. uk/TSD9%20HSUV%20values- FINAL.pdf [Accessed 2012 Apr 10]